Melatonin receptors: potential targets for central nervous system disorders

Bibliography

• LERNER AB, CASE JD, TAKAHASHI Y, LEE TH, MORI W: Isolation of melatonin, the pineal factor that lightens melanocytes. J. Am. Chem. Soc. (1958) 80:2587.
   Web of Science ®Google Scholar
• ARENDT J: Melatonin and the Mammalian Pineal Gland. Chapman and Hall, London (1995).
   Google Scholar
• YU H-S, REITER RJ: Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications. CRC Press, Boca Raton (1993).
   Google Scholar
• EBISAWA T, KARNE S, LERNER MR, REPPERT SM: Expres-sion cloning of a high-affinity melatonin receptor from Xenopusdermalmelanophores. Proc. Natl. Acad. Sci. USA (1994) 91:6133–6137.
   PubMed Web of Science ®Google Scholar
• REPPERT SM, WEAVER DR, CASSONE VM, GODSON C,KOLAKOWSKI L: Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differen-tially expressed in chick brain. Neuron (1995) 15:1003–1015.
   PubMed Web of Science ®Google Scholar
• REPPERT SM, WEAVER DR, EBISAWA T, MAHLE CD, KO-LAKOWSKI LF: Cloning of a melatonin-related receptor from human pituitary. FEBS Lett. (1996) 386:219–224.
   PubMed Web of Science ®Google Scholar
• REPPERT SM, GODSON C, MAHLE CD et al.: Molecular characterisation of a second melatonin receptor ex-pressed in human retina and brain: the melt b melatonin receptor. Proc. Natl Acad. Sci. USA (1995) 92:8734–8738.
   PubMed Web of Science ®Google Scholar
• REPPERT SM, WEAVER DR, EBISAWA T: Cloning and characterisation of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron (1994) 13:1177–1185.
   PubMed Web of Science ®Google Scholar
• LIU F, YUAN H, SUGAMORI KS et al.: Molecular andfunctional characterisation of a partial cDNA encoding a novel chicken brain melatonin receptor. FEBS Lett (1995) 374:273–278.
   PubMed Web of Science ®Google Scholar
• ROCA A, GODSON C, WEAVER DR REPPERT SM: Structure,characterisation, and expression of the gene encoding the mouse meha melatonin receptor. Endocrinology (1996) 137:3469–3477.
   PubMed Web of Science ®Google Scholar
• MAZZUCCHELLI C, PANNACCI M, NONNO R et al.: Themelatonin teceptor in the human brain: cloning experi-ments and distribution studies. Mol. Brain Res. (1996) 39:117–126.
   PubMedGoogle Scholar
• MORGAN PJ, DAVIDSON G, LAWSON W, BARRETT P: Bothpertussis toxin-sensitive and -insensitive G-proteins link melatonin receptor to inhibition of adenylate cy-clase in the ovine pars tuberalis. j Neuroendocrinol. (1990) 2:773–776.
   PubMed Web of Science ®Google Scholar
• CARLSON LL, WEAVER DR, REPPERT SM: Melatonin recep -tors and signal transduction during development in Siberian hamsters (Phodopus sungorus). Dev. Brain Res. (1991) 59:83–88.
   PubMedGoogle Scholar
• STANKOV B, BIELLA G, PANARA C eta].: Melatonin signaltransduction and mechanism of action in the central nervous system: using the rabbit cortex as a model. Endocrinology (1992) 130:2152–2159.
   Google Scholar
• VAKKURI 0, LEPPALUOTO J, VUOLTENNAHO 0: Devel-opment and validation of a melatonin radioimmunoas - say using radioiodinated melatonin as a tracer. Acta Endocrinol. (1984) 106:152–157.
   PubMedGoogle Scholar
• MORGAN PJ, BARRETT P, HOWELL E, HELLIWELL R: Mela-tonin receptors: localisation, molecular pharmacology and physiological significance. Neurochem. Int. (1994) 24:101–146.
   PubMed Web of Science ®Google Scholar
• REPPERT SM, WEAVER DR, RIVKEES SA, STOPA EG: Puta-tive melatonin receptors in a human biological clock. Science (1988) 242:78–81.
   PubMed Web of Science ®Google Scholar
• STARKEY SJ, WALKER MP, BERESFORD UM, HAGAN RM:Modulation of the rat suprachiasmatic circadian clock by melatonin in vitro. Neuroreport (1995) 6:1947–1951.
   PubMed Web of Science ®Google Scholar
• SONG Y, TAM PC, POON AMS, BROWN GM, PANG SF: 2[1251]-Iodomelatonin-binding sites in the human kid-ney and the effect of guanosine 5'-0-(3-thiotriphos-phate). j Clin. Endocrinol. Metab. (1995) 80:1560–1565.
   PubMed Web of Science ®Google Scholar
• CALVO JR, RAFII-EL-IDRISSI M, POZO D, GUERRERO JM:Immunomodulatory role of melatonin: specific bind-ing sites in human and rodent lymphoid cells. j Pineal Res. (1995) 18:119–126.
   PubMed Web of Science ®Google Scholar
• PONTOIRE C, BERNARD M, SILVAIN C, COLLIN JP, VOISIN P: Characterisation of melatonin binding sites in chicken and human intestines. Eur. Pharmacol. MoL Pharmacol (1993) 247:111–118.
   PubMed Web of Science ®Google Scholar
• POON AMS, MAK ASY, LUK HT: Melatonin and 24125II4o-domelatonin binding sites in the human colon. Endo-crine Res. (1996) 22:77–94.
   PubMedGoogle Scholar
• STANKOV BS, CAPSONI S, LUCINI V et al: Autoradiog-raphic localisation of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus. Neuroscience (1993) 52:459–468.
   PubMed Web of Science ®Google Scholar
• VISWANATHAN M, LAITINEN J, SAAVEDRA JM: Expressionof melatonin receptors in arteries involved in ther-moregulation. Proc. Natl. Acad. Sci. USA (1990) 87:6200–6203.
   PubMed Web of Science ®Google Scholar
• WATSON AJ, AGARWAL P, GOGGINS GD, RYAN E, MAHLECD: Evidence that the melta melatonin receptor medi-ates melatonin-induced vasoconstriction of rat caudal and cerebral vessels. Soc. Neurosci. Abstr. (1996) 22:1400.
   Google Scholar
• KRAUSE DN, DUBOCOVICH ML, EDVINSSON L eta].: MI4Amelatonin receptors in human and rat cerebral and peripheral arteries: mRNA expression and functional pharmacology. Soc. Neurosci. Abstr. (1996) 22:1400.
   Google Scholar
• CAPSONI S, STANKOV B, FRASCHINI F: Reduction of regional cerebral blood flow by melatonin in young rats. Neuroreport (1995) 6:1346–1348.
   PubMed Web of Science ®Google Scholar
• DUNCAN MJ, TAKAHASHI J, DUBOCOVICH M: 2[125I]4odomelatonin binding sites in hamster brain mem- branes: pharmacological characteristics and regional distribution. Endocrinology (1988) 122: 1825-1833.
   Google Scholar
• PICKERING DS, NILES LP: Expression of nanomolar-af-finity binding sites for melatonin in syrian hamster RPMI-1846 melanoma cells. Cellular Signalling (1992) 4:201–207.
   PubMed Web of Science ®Google Scholar
• DUBOCOVICH ML: Melatonin receptors: are there mul-tiple subtypes? Trends Pharmacol Sci. (1995) 16:50–56.
   Google Scholar
• MOLINARI EJ, NORTH PC, DUBOCOVICH ML: 24125II-Iodo-5-methoxycarbonylamino-N-acetyltryptamine: a radi-oligand for the characterisation of melatonin ML2 binding sites. Eur. j Pharmacol. (1996) 301:159–168.
   PubMed Web of Science ®Google Scholar
• TAKAKI KS, WATSON BT, DESHPANDE RA et al: Identifi-cation of novel benzimidazoles with high affinity and specificity for the melatonin ML2 binding site. Soc. Neurosci. Abstr. (1996) 22:1400.
   Google Scholar
• REDMAN J, ARMSTRONG S, NG K: Free running activity rhythms in the rat: entrainment by melatonin. Science (1983) 219:1089–1091.
   PubMed Web of Science ®Google Scholar
• SACK RL, LEWY AJ, HUGHES RJ, MCARTHUR AJ, BLOOD ML: Melatonin as a chronobiotic drug. Drug News Per-spect. (1996) 9:325–332.
   Web of Science ®Google Scholar
• ARENDT J, ALDHOUS M: Further evaluation of the treat-ment of jet-lag with melatonin: a double-blind cross-over study. Ann. Rev. Chronopharmacol. (1988) 5:53–55.
   Google Scholar
• PETRIE K, DAWSON AG, THOMPSON L, BROOK R: A double-blind trial of me latonin as a treatment for jet lag in international cabin crew. Biol. Psychiat. (1993) 33:526–530.
   PubMed Web of Science ®Google Scholar
• DAHLITZ M, ALVAREZ B, VIGNAU J et al.: Delayed sleepphase syndrome response to melatonin. Lancet (1991) 337:1121–1124.
   PubMed Web of Science ®Google Scholar
• SACK RL, LEWY AJ, BLOOD ML, STEVENSON J, KEITH LD: Melatonin administration to blind people: phase ad-vances and entrainment. J. Biol. Rhythms (1991) 6:249–261.
   PubMed Web of Science ®Google Scholar
• FOLKHARD S, ARENDT J, CLARK M: Can melatonin im-prove shift workers' tolerance of the night shift? Some preliminary findings. Chronobiol Internal (1993) 10:315–320.
   PubMed Web of Science ®Google Scholar
• ANTON-TAY F, DIAZ JL, FERNANDEZ-GUARDIOLA A: On the effect of melatonin upon human brain: its possible therapeutic implications. Life Sci. (1971) 10:841–850.
   Web of Science ®Google Scholar
• DOLLINS AB, ZHDANOVA IV, WURTMAN RJ, LYNCH HJ, DENG MU: Effect of inducing nocturnal serum mela-tonin concentrations in daytime on sleep, mood, body temperature, andperformance. Proc. Natl. Acad. Sci USA (1994) 91:1824–1828.
   PubMed Web of Science ®Google Scholar
• ATTENBURROW MEJ, COWEN PJ, SHARPLEY AL: Low dosemelatonin improves sleep in healthy middle-aged sub-jects. Psychopharmacology (1996) 126:179–181.
   PubMed Web of Science ®Google Scholar
• ZHDANOVA IV, WURTMAN RJ, MORABITO C, PIOTROVSKA VR, LYNCH HJ: Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep (1996) 19:423–431.
   PubMed Web of Science ®Google Scholar
• ATTENBURROW MEJ, DOWLING B, SHARPLEY AL, COWENPJ: Case-control study of evening melatonin concentra-tion in primary insomnia. Br. Med. J. (1996) 312:1263–1264.
   PubMedGoogle Scholar
• HAJAK G, RODENBECK A, STAEDT J et al: Nocturnalplasma melatonin levels in patients suffering from chronic primary insomnia. J. Pineal Res. (1995) 19:116–122.
   PubMed Web of Science ®Google Scholar
• MILES LE, DEMENT WC: Sleep and aging. Sleep (1980) 3:119–220.
   Web of Science ®Google Scholar
• HAIMOV I, LAVIE P: Potential of melatonin replacement therapy in older patients with sleep disorders. Drugs and Aging (1995) 7:75–78.
   PubMed Web of Science ®Google Scholar
• SACK RL, LEWY AJ, ERB DL, VOLLMER WM, SINGER CM: Human melatonin production decreases with age. J. Pineal Res. (1986) 3:379–388.
   PubMed Web of Science ®Google Scholar
• HAIMOV I, LAUDON M, ZISAPEL N etal.: Sleep disorders and melatonin rhythms in elderly people. Br. Med. J. (1994) 309:167.
   Google Scholar
• HAIMOV I, LAVIE P, LAUDON M et al.: Melatonin replace-ment therapy of elderly insomniacs. Sleep (1995) 18:598–603.
   PubMed Web of Science ®Google Scholar
• GARFINKEL D, LAUDON M, NOF D, ZISAPEL N: Improve-ment of sleep quality in elderly people by controlled-release melatonin. Lancet (1995) 346:541–544.
   PubMed Web of Science ®Google Scholar
• GREEN AR, NUTT DJ, COWEN PJ: Using Ro-1788 to inves-tigate the benzodiazepine receptor in viva studies on the anticonvuls ant and sedative effect of melatonin and the convulsant effect of the benzodiazepine Ro 05-3663. Psychopharmacology (1982) 78:293–295.
   PubMed Web of Science ®Google Scholar
• NILES IP, PICKERING DS, ARCISZEWSKI MA: Effects of chronic melatonin administration on GABA and diaze-pam binding in rat brain. J. Neural Trans. (1987) 70:117–124.
   PubMed Web of Science ®Google Scholar
• CHAMPNEY TH, CHAMPNEY J-A: Novel anticonvulsantaction of chronic melatonin in gerbils. Neuroreport (1992) 3:1152–1154.
   PubMed Web of Science ®Google Scholar
• CHAMPNEY TH, SANCHEZ-FORTE M, MUNOZ-HOYOS A etal: Anticonvulsant effects of melatonin in humans: two case studies. Soc. Neurosci Absft-. (1995) 21:1964.
   Google Scholar
• GOLOMBEK DA, MARTINI M, CARDINALI DP: Melatonin as an anxiolytic in rats: time dependence and interac-tion with the central GABAergic system. Eur. j Pharma-col. (1993) 237:231–236.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL NE, SACK DA, CARPENTER CJ et al.: Antide-pressant effects of light in seasonal affective disorder. Am. J. Psychiat. (1985) 142:163–170.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL NE, SACK DA, JACOBSEN FM eta].: Melatonin in seasonal affective disorder and phototherapy. J. Neural Trans. (1986) 21 (Sup pl.) :257–267.
   Google Scholar
• CARMAN JS, POST RM, BUSVVELL R, GOODWIN FK: Nega-tive effects of melatonin on depression. Am. j Psychiat (1976) 133:1181–1186.
   PubMed Web of Science ®Google Scholar
• DUBOCOVICH ML, MOGILNICKA E, ARESO PM: Antide-pressant-like activity of the melatonin receptor antago-nist, luzindole (N-0774), in the mouse behavioural despair test.Eur.j Pharmacol (1990) 182:313–325.
   PubMed Web of Science ®Google Scholar
• GUARDIOLA-LEMAITRE B, DELAGRANGE P: Melatonin analogues: from pharmacology to clinical application. Eur. J. Med. Chem. (1995) 30:644s–651s.
   Google Scholar
• DUBOCOVICH ML: Luzindole (N-0774): a novel mela-tonin receptor antagonist. J. Pharmacol. Exp. Ther. (1988) 246:902–910.
   PubMed Web of Science ®Google Scholar
• SUGDEN D: Effect of putative melatonin antagonists on melatonin-induced pigment aggregation in isolated Xenopus laevis melanophores. Eur. j Pharmacol (1992) 213:405–408.
   PubMed Web of Science ®Google Scholar
• LE GOUIC S, DELAGRANGE P, ATGIE C et aL: Effects of both a melatonin agonist and antagonist on seasonal changes in body mass and energy intake in the garden dormouse. mt. J. Obesi (1996) 20:661–667.
   PubMed Web of Science ®Google Scholar